Plasma malondialdehyde (MDA) levels in breast and lung cancer patients


Gonenc A., Ozkan Y., Torun M., Simsek B.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol.26, no.2, pp.141-144, 2001 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 2
  • Publication Date: 2001
  • Doi Number: 10.1046/j.1365-2710.2001.00334.x
  • Journal Name: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.141-144
  • Keywords: breast cancer, lipid peroxidation, lung cancer, malondialdehyde (MDA), LIPID-PEROXIDATION, MAMMOGRAPHIC DYSPLASIA, ANTIOXIDANT FUNCTIONS, PREMENOPAUSAL WOMEN, SERUM-CHOLESTEROL, BETA-CAROTENE, VITAMIN-C
  • Gazi University Affiliated: Yes

Abstract

Objective: To measure the levels of malondialdehyde (MDA), a marker of lipid peroxidation, in patients with breast and lung cancer.